Article

Janet Freeman-Daily on Genomic Testing for Lung Cancer Patients

Author(s):

Janet Freeman-Daily

Janet Freeman-Daily, a patient with metastatic lung cancer and a CURE contributor, discusses the importance of genomic testing for patients with lung cancer.

Janet Freeman-Daily, a patient with metastatic lung cancer and a CURE contributor, discusses the importance of genomic testing for patients with lung cancer. We spoke with Freeman-Daily during the 2015 annual meeting of the American Society of Clinical Oncology (ASCO), a gathering of nearly 30,000 oncology professionals in Chicago.

Newsletter

Stay up to date on cancer updates, research and education

Subscribe Now!
Related Videos
Dr. Josh Sabari and Terri Conneran
Dr. Rosario Ligestri
image of man.
Related Content
Image of a head and neck
September 16th 2025

Understanding Head and Neck Cancer: A Guide for Newly Diagnosed Patients

Gina Mauro
illustration of gynecologic cancer
September 16th 2025

What Does An Early-Stage Gynecologic Cancer Diagnosis Mean?

Ryan Scott
Dr. Paul Gellhaus says PSA testing and modern biopsy methods ease fears and reassure patients, making early prostate cancer detection safe and valuable.
September 16th 2025

Early Prostate Cancer Detection: Why PSA Screening Matters

Dr. Paul Gellhaus
Image of melanoma
September 16th 2025

Early-Stage Melanoma: Diagnosis, Treatment and Next Steps

Ryan Scott
Kristen Dahlgren of the Cancer Vaccine Coalition spoke with CURE about why she remains hopeful for the future or cancer vaccines.
September 16th 2025

Could Cancer Vaccines Become a Reality Within the Next Decade?

Kristen Dahlgren
Dr. Suresh S. Ramalingam explains that patients with stage 3 lung cancer who undergo chemotherapy and radiation may develop radiation pneumonitis.
September 16th 2025

Managing Lung Inflammation After Chemoradiation and Tagrisso

Dr. Suresh S. Ramalingam